Picture of Labomar SpA logo

LBM Labomar SpA Share Price

0.000.00%
it flag iconLast trade - 00:00
HealthcareBalancedSmall Cap

Momentum

Relative Strength (%)
1m-1.81%
3m+17.4%
6m+18.24%
1yr+5.08%
Volume Change (%)
10d/3m-7.5%
Price vs... (%)
52w High-1.96%
50d MA+1.18%
200d MA+15.07%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)23.26
PEG Ratio (f)1.51
EPS Growth (f)18.25%
Dividend Yield (f)1.31%
Valuation (ttm)IndustryMarket
Price to Book Value3.62
Price to Tang. Book19.63
Price to Free Cashflow51.58
Price to Sales2.01
EV to EBITDA12.36

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital9.9%
Return on Equity12.71%
Operating Margin10.29%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total Revenue€m43.4748.3461.0665.4191.8293.7101.317%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+2.7-2.51+16.12+67.52-42.4+18.71+17.95n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Labomar SpA EPS forecast chart

Profile Summary

LABOMAR S.R.L. is an Italy-based company, which produces dietary supplements, in either solid format or as liquids. The Company's oral solid products include chewable tablets, swallable tablets, coated tablets, gastro-resistant tablets, time release tablets, micro tablets, hard plant or animal gelatine capsules, oro dispersible powders, and water dispersible powders. Its oral liquid products include syrups, hydroglyceric and hydroalcoholic suspensions, solutions, emulsions, and nanoemulsions. The Company serves companies operating in the medical information sector, in distribution channels in chemist and herbalists shops, retail stores of products for athletes and retail organization.

Directors

Last Annual
December 31st, 2022
Last Interim
December 31st, 2022
Incorporated
January 7th, 1999
Public Since
October 5th, 2020
No. of Employees
360
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
it flag iconBorsa Italiana
Shares in Issue
18,484,043
Blurred out image of a map
Address
Via N. Sauro, 35/l, ISTRANA, 31036
Web
https://labomar.com/
Phone
Contact
Claudio De Nadai
Auditors
Ernst & Young SpA

LBM Share Price Performance

Upcoming Events for LBM

Similar to LBM

Picture of Friulchem SpA logo

Friulchem SpA

it flag iconBorsa Italiana

Picture of Kolinpharma SpA logo

Kolinpharma SpA

it flag iconBorsa Italiana

Picture of Pharmanutra SpA logo

Pharmanutra SpA

it flag iconBorsa Italiana

Picture of Pierrel SpA logo

Pierrel SpA

it flag iconBorsa Italiana

FAQ